Annual Accounts Payable
$72.00 M
+$31.32 M+76.99%
December 31, 2024
Summary
- As of March 11, 2025, AXSM annual accounts payable is $72.00 million, with the most recent change of +$31.32 million (+76.99%) on December 31, 2024.
- During the last 3 years, AXSM annual accounts payable has risen by +$58.85 million (+447.53%).
- AXSM annual accounts payable is now at all-time high.
Performance
AXSM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$72.00 M
+$7.74 M+12.05%
December 31, 2024
Summary
- As of March 11, 2025, AXSM quarterly accounts payable is $72.00 million, with the most recent change of +$7.74 million (+12.05%) on December 31, 2024.
- Over the past year, AXSM quarterly accounts payable has stayed the same.
- AXSM quarterly accounts payable is now at all-time high.
Performance
AXSM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AXSM Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +77.0% | 0.0% |
| 3 y3 years | +447.5% | 0.0% |
| 5 y5 years | +557.9% | +557.9% |
AXSM Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +447.5% | at high | +471.6% |
| 5 y | 5-year | at high | +557.9% | at high | +668.9% |
| alltime | all time | at high | >+9999.0% | at high | +9395.8% |
Axsome Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $72.00 M(+77.0%) | $72.00 M(+12.1%) |
| Sep 2024 | - | $64.25 M(+4.7%) |
| Jun 2024 | - | $61.34 M(+14.0%) |
| Mar 2024 | - | $53.79 M(+32.2%) |
| Dec 2023 | $40.68 M(+5.4%) | $40.68 M(+39.8%) |
| Sep 2023 | - | $29.10 M(-32.3%) |
| Jun 2023 | - | $42.96 M(+20.1%) |
| Mar 2023 | - | $35.77 M(-7.3%) |
| Dec 2022 | $38.60 M(+193.6%) | $38.60 M(+200.6%) |
| Sep 2022 | - | $12.84 M(-33.9%) |
| Jun 2022 | - | $19.43 M(+54.3%) |
| Mar 2022 | - | $12.60 M(-4.2%) |
| Dec 2021 | $13.15 M(-2.6%) | $13.15 M(-1.7%) |
| Sep 2021 | - | $13.38 M(+15.2%) |
| Jun 2021 | - | $11.61 M(-20.6%) |
| Mar 2021 | - | $14.62 M(+8.3%) |
| Dec 2020 | $13.50 M(+23.4%) | $13.50 M(+19.3%) |
| Sep 2020 | - | $11.32 M(+20.8%) |
| Jun 2020 | - | $9.36 M(-23.2%) |
| Mar 2020 | - | $12.19 M(+11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $10.94 M(+196.8%) | $10.94 M(+15.8%) |
| Sep 2019 | - | $9.45 M(+53.9%) |
| Jun 2019 | - | $6.14 M(+78.7%) |
| Mar 2019 | - | $3.43 M(-6.9%) |
| Dec 2018 | $3.69 M(+7.3%) | $3.69 M(-11.5%) |
| Sep 2018 | - | $4.17 M(+31.2%) |
| Jun 2018 | - | $3.18 M(-18.1%) |
| Mar 2018 | - | $3.87 M(+12.8%) |
| Dec 2017 | $3.44 M(-15.8%) | $3.44 M(+16.7%) |
| Sep 2017 | - | $2.94 M(-27.1%) |
| Jun 2017 | - | $4.04 M(-14.8%) |
| Mar 2017 | - | $4.74 M(+16.2%) |
| Dec 2016 | $4.08 M(+115.7%) | $4.08 M(+5.5%) |
| Sep 2016 | - | $3.87 M(+27.4%) |
| Jun 2016 | - | $3.04 M(+65.8%) |
| Mar 2016 | - | $1.83 M(-3.3%) |
| Dec 2015 | $1.89 M(+149.6%) | $1.89 M(+10.3%) |
| Sep 2015 | - | $1.72 M(+59.7%) |
| Jun 2015 | - | $1.07 M(+41.7%) |
| Dec 2014 | $758.20 K(+376.0%) | $758.20 K |
| Dec 2013 | $159.30 K | - |
FAQ
- What is Axsome Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Axsome Therapeutics?
- What is Axsome Therapeutics annual accounts payable year-on-year change?
- What is Axsome Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly accounts payable year-on-year change?
What is Axsome Therapeutics annual accounts payable?
The current annual accounts payable of AXSM is $72.00 M
What is the all time high annual accounts payable for Axsome Therapeutics?
Axsome Therapeutics all-time high annual accounts payable is $72.00 M
What is Axsome Therapeutics annual accounts payable year-on-year change?
Over the past year, AXSM annual accounts payable has changed by +$31.32 M (+76.99%)
What is Axsome Therapeutics quarterly accounts payable?
The current quarterly accounts payable of AXSM is $72.00 M
What is the all time high quarterly accounts payable for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly accounts payable is $72.00 M
What is Axsome Therapeutics quarterly accounts payable year-on-year change?
Over the past year, AXSM quarterly accounts payable has changed by $0.00 (0.00%)